Use of donor lymphocyte infusions (DLI) for the treatment of relapse after allogeneic bone marrow transplantation (ABMT): Effective GVT in chronic myeloid leukemia (CML) with no clinical GVHD.

被引：0

作者：

Hahn, TE ^{[1
]}

Alam, AR ^{[1
]}

Miller, A ^{[1
]}

Meteer, J ^{[1
]}

Dascomb, S ^{[1
]}

Baer, MR ^{[1
]}

Bambach, B ^{[1
]}

Bernstein, S ^{[1
]}

Bernstein, Z ^{[1
]}

Chanan-Khan, A ^{[1
]}

Czuczman, M ^{[1
]}

Slack, J ^{[1
]}

Wetzler, M ^{[1
]}

Becker, J ^{[1
]}

Stewart, C ^{[1
]}

McCarthy, PL ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

来源：

BLOOD | 2001年 / 98卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5239

引用

页码：366B / 366B

页数：1

共 50 条

[31] Bone marrow transplantation for treatment of chronic myeloid leukemia (CML) in childhood
Suttorp, M
BONE MARROW TRANSPLANTATION, 1998, 21 : S84 - S84
[32] Donor leukocyte infusions (DLI) for the treatment of relapsed hematological malignancies after allogeneic elutriated bone marrow transplantation (BMT).
Seber, A
Noga, SJ
Harris, D
Hattenburg, C
Fuchs, EJ
BLOOD, 1996, 88 (10) : 1030 - 1030
[33] The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
Conchon, Monika
Sanabani, Sabri S.
Bendit, Israel
Dinardo, Carla Luana
Dias, Lucia
Fischer Chamone, Dalton de Alencar
Dorlhiac-Llacer, Pedro Enrique
Dulley, Frederico Luiz
JOURNAL OF TRANSPLANTATION, 2009, 2009
[34] Allogeneic stem cell transplantation (ASCT) and donor lymphocyte infusions (DLI) in the management of chronic myelomonocytic leukemia (CMML).
Elliott, MA
Tefferi, A
Hogan, WJ
Letendre, L
Gastineau, DA
Ansell, SM
Dispenzieri, A
Gertz, MA
Inwards, DJ
Lacy, MQ
Micallef, IN
Porrata, LF
Litzow, MR
BLOOD, 2005, 106 (11) : 441B - 442B
[35] Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation
Baurmann, H
Nagel, S
Binder, T
Neubauer, A
Siegert, V
Huhn, D
BLOOD, 1998, 92 (10) : 3582 - 3590
[36] Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia
Humblet-Baron, S
Baron, F
Beguin, Y
Chachati, A
Bury, J
Morelon, E
Kreis, H
TRANSPLANTATION, 2003, 76 (10) : 1531 - 1532
[37] Combined use of T cell depleted bone marrow transplants (TCDBMT) with donor leukocyte infusions (DLI) for treatment of patients with chronic myelogenous leukemia (CML).
Papadopoulos, EB
Young, JW
Barnett, L
Childs, BH
Castro-Malaspina, H
Jakubowski, A
Collins, N
Mackinnon, S
OReilly, RJ
BLOOD, 1998, 92 (10) : 322A - 322A
[38] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
GOLDMAN, JM
EXPERIMENTAL HEMATOLOGY, 1987, 15 (05) : 511 - 511
[39] LEUKEMIA RELAPSE IN DONOR CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
NEWBURGER, PE
LATT, SA
PESANDO, JM
GUSTASHAW, K
POWERS, M
CHAGANTI, RSK
OREILLY, RJ
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12): : 712 - 714
[40] Prevention of relapse after lymphocyte depleted allogeneic bone marrow transplantation by preemptive donor leukocyte infusions in patients with high risk of relapse
Schaap, N
Schattenberg, A
Bär, B
Preijers, F
De Witte, T
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 12 - 12

← 1 2 3 4 5 →